Carl LeBel, Chief Scientific Officer at Otonomy, Inc. (OTIC), sold 21,250 shares at $24.36 ($518K) on 2015-09-21, disclosed to the SEC on 2015-09-22.
Scheduled sale ($518k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FREQ | SELL | 2022-02-18 | $7K | — | Filing → |
| FREQ | SELL | 2022-02-16 | $4K | — | Filing → |
| OTIC | SELL | 2016-11-22 | $384K | — | Filing → |